BOUT IBD Breakout Opportunities ETF

Seeks to track, before fees and expenses, the IBD Breakout Stocks Index. The Index leverages decades of Investor's Business Daily research and seeks to identify stock breakout opportunities, or stocks poised to experience a period of sustained price growth beyond the security's recent "resistance level", with consideration for various market conditions. The Index starts with all U.S. listed common stocks and ADRs with a share price above $10 and a daily volume of $5 million. The Index then determines a “base price” for each remaining stock. When a stock reaches a recent high in price and at least four weeks elapse without that high being surpassed, this price is identified as the base price. This base is used to determine those stocks nearing breakouts and those stocks experiencing breakouts. In making this determination, the Index utilizes an algorithm that analyses the following trends for each stock: 1. The length of time from the establishment of the base to the current date. 2. The difference in price between the base and the lowest subsequent price for the stock. 3. The percentage difference between the current price and the high at the start of the base. 4. The percentage difference in price from the stock’s lowest price subsequent to the establishment of the base and its current price. 5. The percentage change in the stock’s price in each of the last three weeks. Based upon this technical analysis, the Index eliminates all stocks not identified as nearing a breakout or currently breaking out. Each of the remaining stocks is chosen for inclusion in the Index. The Index is also designed to be responsive to equities market conditions that provide fewer opportunities to invest in stocks with breakout potential. Upon the occurrence of certain market signals identified by the Index Provider as forecasting a downturn in the equities market, the Index will allocate 50% of its weight to a portfolio composed of U.S. Treasury bills with maturities of one- to three- months (“cash positions”) to approximate an investment in cash. The Index weights the selected stocks using a complex, multi-step scoring process. The Index is rebalanced and reconstituted weekly. This weekly rebalancing and reconstituting of the Index will cause the Fund to have a higher portfolio turnover rate than similar funds.

$32.31  +0.48 (1.52%)
As of 08/10/2022 11:48:32 EST     IEX book   CBOE book

---

ETF Information

---

Sponsor:     Innovator Funds
Category1:  US Equity
Category2:  Broad Market
Category3:  Multi-cap
Morningstar category:  Large Blend
Leverage factor:  1.00
Note: Uses downside hedging
Inception date:  09/13/2018
Index tracking method: Passive replication
Current yield:  0.00%
Historical average yield:  0.04%
Market cap:  $15,864,500
Average volume:  4,176
Fees:     0.8000%

---

Index Information

---

IBD Breakout Stocks Index
Index symbol:  BOUTIndex
Provider:   Investors Business Daily
Index weighting:   Composite scores
Index inception date:  01/01/1900
Backtesting data exists:  
Rebalanced:  Weekly
Reconstituted:  Weekly
Factors used to select securities:
Other